The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Effects of Testosterone Treatment in Older Men
Open accessAbstract
BACKGROUND: Serum testosterone concentrations decrease as men age, but benefits of raising testosterone levels in older men have not been established. METHODS: We assigned 790 men 65 years of age or older with a serum testosterone concentration of less than 275 ng per deciliter and symptoms suggesting hypoandrogenism to receive either testosterone gel or placebo gel for 1 year. Each man participated in one or more of three trials--the Sexual Function Trial, the Physical Function Trial, and the Vitality Trial. The primary outcome of each of the individual trials was also evaluated in all participants. RESULTS: Testosterone treatment increased serum testosterone levels to the mid-normal range for men 19 to 40 years of age. The increase in testosterone levels was associated with significantly increased sexual activity, as assessed by the Psychosexual Daily Questionnaire (P<0.001), as well as significantly increased sexual desire and erectile function. The percentage of men who had an increase of at least 50 m in the 6-minute walking distance did not differ significantly between the two study groups in the Physical Function Trial but did differ significantly when men in all three trials were included (20.5% of men who received testosterone vs. 12.6% of men who received placebo, P=0.003). Testosterone had no significant benefit with respect to vitality, as assessed by the Functional Assessment of Chronic Illness Therapy-Fatigue scale, but men who received testosterone reported slightly better mood and lower severity of depressive symptoms than those who received placebo. The rates of adverse events were similar in the two groups. CONCLUSIONS: In symptomatic men 65 years of age or older, raising testosterone concentrations for 1 year from moderately low to the mid-normal range for men 19 to 40 years of age had a moderate benefit with respect to sexual function and some benefit with respect to mood and depressive symptoms but no benefit with respect to vitality or walking distance. The number of participants was too few to draw conclusions about the risks of testosterone treatment. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT00799617.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“there is accumulating evidence against a link between testosterone therapy and prostate cancer development.”
From Evaluation and Management of Testosterone Deficiency: AUA Guideline (2018) · cites this paper as [24]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the ‘Testosterone Trials’, treatment with testosterone improved participants’ results in the 6 min walk test compared with placebo (20.5% versus 12.6%; P = 0.003)53.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [53]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Randomized controlled trials have shown that there is not a significant increase in the rate of a prostate cancer diagnosis in older, testosterone deficient men who were treated with testosterone compared to placebo.”
From Evaluation and Management of Testosterone Deficiency: AUA Guideline (2018) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In trials, patients with low testosterone have demonstrated statistically significant improvements in erectile function, 24 sex drive, 24 anemia, 25 bone mineral density, 26 lean body mass, 27 and depressive symptoms. 24”
From Evaluation and Management of Testosterone Deficiency: AUA Guideline (2018) · cites this paper as [24]
In the citing paper
“Testosterone supplementation is also shown to benefit other aspects of health, including sexual function, physical function, vitality, quality of life and improved mood [109, 111].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [111]
In the citing paper
“Of note, potential improvements in muscle (and lean) mass may not directly result in improved muscle function214,215.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [214]
In the citing paper
“In the large T Trials, sexual function improved modestly with testosterone treatment,”
From Hypogonadism and male obesity: Focus on unresolved questions (2018) · cites this paper as [37]
In the citing paper
“suggesting that even older men with a relatively high comorbid burden (37% had diabetes and 15% a previous myocardial infarction) can respond to testosterone.37”
From Hypogonadism and male obesity: Focus on unresolved questions (2018) · cites this paper as [37]
In the citing paper
“In the Testosterone Trials of stringently selected symptomatic men with a baseline testosterone averaging < 9.5 nmol/L (275 ng/dL) for no apparent reason other than age, testosterone treatment had a modest benefit in sexual function, and some benefit with respect to mood and depressive symptoms (15).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“In an intensive lifestyle randomized controlled trial (RCT) of relatively healthy obese middle-aged men, 15% weight loss increased the mean International Index of Erectile Function (IIEF) score by 3.10, which is clinically meaningful (23) and similar to the increase of 2.64 reported in the Testosterone Trials, although those men were older (15).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“Although head-to-head studies are lacking, the efficacy reported for PDE5 inhibitors is greater than that reported for lifestyle intervention and testosterone treatment (15, 25).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“In RCTs of middle-aged and older men, where contraindications have been rigorously excluded and treatment was carefully monitored, short-term testosterone treatment has been associated with a low risk of adverse events (15).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“Although the trial was too small to reliably assess testosterone treatment-associated risks (15)”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“it does provide some assurance about the potential relative short-term safety of testosterone treatment in men without the previously mentioned contraindications.”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“These guideline recommendations are consistent with the exclusion criteria specified in the Testosterone Trials (15).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“In the 12-month Testosterone Trials, the rates of adverse events were similar in the testosterone- and placebo-treated men.”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Development and validation of brief measures of positive and negative affect: The PANAS scales.
Watson, D., Clark, L. A., & Tellegen, A. (1988) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.54.6.1063 · Cited by 32,433
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
More powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715
Pocock, S. J., & Simon, R. (1975) · Biometrics · doi:10.2307/2529712 · Cited by 2,350
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling
Terza, J. V., Basu, A., & Rathouz, P. J. (2008) · Journal of Health Economics · doi:10.1016/j.jhealeco.2007.09.009 · Cited by 1,728
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Self-citationThe International Index of Erectile Function (IIEF): a state-of-the-science review
Rosen, R., Cappelleri, J. C., & Gendrano, N. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900857 · Cited by 1,050
Self-citationRedelmeier, D. A., Bayoumi, A. M., Goldstein, R. S., & Guyatt, G. H. (1997) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.155.4.9105067 · Cited by 1,029
Flagged first, then by citations
2 of the 40 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Ware J, Kosinski M. SF-36 Physical and Mental Health Summary Scales: a manual for users of Version 1, Second Edition. Lincoln, RI: Quality Metric, 2005.
Cited by
Sorted by citations
Items 301–400 of 891
Breaking News — Testosterone Treatment and Fractures in Older Men
Grossmann, M., & Anawalt, B. D. (2024) · New England Journal of Medicine · doi:10.1056/nejme2313787 · Cited by 20
From sex hormone decrease to hormonal treatment: impacts on cardiovascular risk with ageing
Fontaine, C., Gosset, A., Davezac, M., Buscato, M., Grouthier, V., Renault, M., Henrion, D., Trémollières, F., Schumacher, M., Lenfant, F., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf086 · Cited by 19
Fatigue in inflammatory bowel disease: a problematic ailment
Qazi, T. (2020) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000644 · Cited by 19
Testosterone, Diabetes Risk, and Diabetes Prevention in Men
Yeap, B. B., & Wittert, G. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.11.004 · Cited by 19
Ellenberg, S. S., & Shaw, P. A. (2022) · NEJM Evidence · doi:10.1056/evidctw2100020 · Cited by 19
Self-citationLee, T.-W., Kao, P., Chen, Y., & Wang, S. (2023) · Gerontology · doi:10.1159/000532062 · Cited by 19
Understanding the development of sarcopenic obesity
Gross, D. C., Cheever, C. R., & Batsis, J. A. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2267672 · Cited by 19
Cruickshank, M., Hudson, J., Hernández, R. A., Aceves‐Martins, M., Quinton, R., Gillies, K., Aucott, L. S., Kennedy, C., Manson, P. D., Oliver, N. S., et al. (2024) · Health Technology Assessment · doi:10.3310/jryt3981 · Cited by 20
Molecular basis of androgen action on human sexual desire
Santi, D., Spaggiari, G., Gilioli, L., Potì, F., Simoni, M., & Casarini, L. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.007 · Cited by 19
Yeap, B. B. (2018) · Asian Journal of Andrology · doi:10.4103/aja.aja_50_17 · Cited by 19
Androgen and estrogen actions on male physical activity: a story beyond muscle
Jardí, F., Laurent, M. R., Dubois, V., Kim, N., Khalil, R., Decallonne, B., Vanderschueren, D., & Claessens, F. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0125 · Cited by 20
Osteosarcopenia: una revisión narrativa
Cedeño‐Veloz, B. A., Bonnardeaux, P. L.-D., & Duque, G. (2018) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2018.09.010 · Cited by 19
Enclomiphene citrate: A treatment that maintains fertility in men with secondary hypogonadism
Earl, J. A., & Kim, E. D. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1612239 · Cited by 19
Marcelli, M., & Mediwala, S. N. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2019-001233 · Cited by 23
Tesch, M. E., Zheng, Y. H., Rosenberg, S. M., Poorvu, P. D., Ruddy, K. J., Tamimi, R. M., Schapira, L., Peppercorn, J. M., Borges, V. F., Come, S. E., et al. (2024) · npj Breast Cancer · doi:10.1038/s41523-024-00680-0 · Cited by 18
Self-citationManagement of male sexual dysfunction after cancer treatment
Kim, P., & Clavijo, R. I. (2020) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2020.08.006 · Cited by 22
Relationships between endogenous and exogenous testosterone and cardiovascular disease in men
Thirumalai, A., & Anawalt, B. D. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09752-7 · Cited by 20
Traish, A. M. (2023) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qead031 · Cited by 18
Tishova, Y. A., Kalinchenko, S. Y., Mskhalaya, G. J., Hackett, G. I., Livingston, M. A., König, C. S., Strange, R. C., Zitzmann, M., Mann, A., Maarouf, A., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15520 · Cited by 18
Androgens and erectile dysfunction: from androgen deficiency to treatment
Wang, Y., & Jiang, R. (2024) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeae030 · Cited by 18
Testosterone therapy in older men: clinical implications of recent landmark trials
Grossmann, M., Anawalt, B. D., & Yeap, B. B. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae071 · Cited by 18
Androgens and depression: a review and update
Nead, K. T. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000477 · Cited by 18
Testosterone and Dehydroepiandrosterone Treatment in Ageing Men: Are We All Set?
Walther, A., & Seuffert, J. (2019) · The World Journal of Men s Health · doi:10.5534/wjmh.190006 · Cited by 20
Gagliano‐Jucá, T., Li, Z., Pencina, K. M., Traustadóttir, T., Travison, T. G., Woodhouse, L. J., Basaria, S. S., Tsitouras, P. D., Harman, S. M., Bhasin, S., et al. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz167 · Cited by 22
Self-citationStraftis, A. A., & Gray, P. B. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16183261 · Cited by 18
Establishing a Framework — Does Testosterone Supplementation Help Older Men?
ORWOLL, E. S. (2016) · New England Journal of Medicine · doi:10.1056/nejme1600196 · Cited by 18
Khera, M., Torres, L. O., Grober, E. D., Morgentaler, A., Miner, M. M., Jones, T. H., Mills, J. N., & Salonia, A. (2025) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeaf036 · Cited by 21
Gregori, G., Celli, A., Barnouin, Y., Paudyal, A., Armamento‐Villareal, R., Napoli, N., Qualls, C., & Villareal, D. T. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab253 · Cited by 19
Effects of androgens on glucose metabolism
Umapathysivam, M. M., Grossmann, M., & Wittert, G. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101654 · Cited by 18
Campbell, K., Muthigi, A., Ghomeshi, A., Schuppe, K. C., Sandler, M. D., & Ramasamy, R. (2023) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s383130 · Cited by 17
Prostate Risk and Monitoring During Testosterone Replacement Therapy
Bhasin, S., & Thompson, I. M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae334 · Cited by 17
Self-citationBusnelli, A., Somigliana, E., & Vercellini, P. (2017) · Human Reproduction · doi:10.1093/humrep/dex032 · Cited by 17
ElKhoury, F. F., Rambhatla, A., Mills, J. N., & Rajfer, J. (2017) · Urology · doi:10.1016/j.urology.2017.07.030 · Cited by 17
Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism
Grabner, M., Hepp, Z., Raval, A. D., Tian, F., & Khera, M. (2018) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2017.11.225 · Cited by 17
Peng, R., Dai, W., & Li, Y. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.03.018 · Cited by 17
Montagna, G., Balestra, S., D’Aurizio, F., Romanelli, F., Benagli, C., Tozzoli, R., Risch, L., Giovanella, L., & Imperiali, M. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-1201 · Cited by 17
UK policy statements on testosterone deficiency
Hackett, G. I., Kirby, M. G., Edwards, D., Jones, T. H., Rees, J., & Muneer, A. (2017) · International Journal of Clinical Practice · doi:10.1111/ijcp.12901 · Cited by 18
Hu, L., Mitchell, L., Zhang, X., Heiselman, D., & Motsko, S. P. (2017) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2017.09.010 · Cited by 16
Testosterone Replacement Therapy
Haymana, C., & Sönmez, A. (2022) · Management of urology · doi:10.1007/978-3-031-12049-7_20 · Cited by 17
Androgen Society Position Paper on Cardiovascular Risk With Testosterone Therapy
Morgentaler, A., Dhindsa, S., Dobs, A. S., Hackett, G. I., Jones, T. H., Kloner, R. A., Miner, M. M., Zitzmann, M., & Traish, A. M. (2024) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.08.008 · Cited by 18
Khera, M., Miner, M. M., Jaffe, J. S., & Pastuszak, A. W. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.10.019 · Cited by 16
Testosterone Replacement Therapy in the Treatment of Depression
Anderson, D. J., Vazirnia, P., Loehr, C. A., Sternfels, W., Hasoon, J. J., Viswanath, O., Kaye, A. D., & Urits, I. (2022) · Health Psychology Research · doi:10.52965/001c.38956 · Cited by 18
Marriott, R. J., Murray, K., Budgeon, C. A., Codd, V., Hui, J., Arscott, G. M., Beilby, J. P., Hankey, G. J., Wittert, G., Wu, F. C. W., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad015 · Cited by 15
Lee, H. S., Han, S. H., Swerdloff, R. S., Pak, Y., Budoff, M. J., & Wang, C. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad511 · Cited by 16
Self-citationMoon, H. W., Park, J. W., Lee, K. W., Jeong, H. C., Choi, J. B., Choi, S. W., Bae, W. J., Cho, H. J., Ha, U., Hong, S., et al. (2017) · The World Journal of Men s Health · doi:10.5534/wjmh.2017.35.1.43 · Cited by 16
Wang, C., Stephens‐Shields, A. J., Derogatis, L. R., Cunningham, G. R., Swerdloff, R. S., Preston, P. E., Cella, D. F., Snyder, P. J., Gill, T. M., Bhasin, S., et al. (2018) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2018.05.008 · Cited by 16
Self-citationAguirre, L. E., Colleluori, G., Robbins, D., Dorin, R. I., Shah, V. O., Chen, R., Jan, I. Z., Qualls, C., Villareal, D. T., & Armamento‐Villareal, R. (2019) · Endocrine · doi:10.1007/s12020-019-02008-6 · Cited by 16
Association of Second-generation Antiandrogens With Depression Among Patients With Prostate Cancer
Nowakowska, M. K., Lei, X. J., Wehner, M. R., Corn, P. G., Giordano, S. H., & Nead, K. T. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.40803 · Cited by 16
Testosterone replacement therapy and erectile dysfunction
Onyeji, I. C., & Clavijo, R. I. (2022) · International Journal of Impotence Research · doi:10.1038/s41443-021-00512-w · Cited by 16
Inoue, Y., Nakamura, K., Kuwahara, Y., Lü, Y., Masuda, N., Horie, S., Okada, H., & Ide, H. (2018) · American Journal of Men s Health · doi:10.1177/1557988318772734 · Cited by 15
Factors, mechanisms and improvement methods of muscle strength loss
Wang, K., Wang, X., & Wang, Y. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1509519 · Cited by 18
Testosterone therapy improves well being and psychological health
Akerman, J., Kovac, J. R., & Lipshultz, L. I. (2017) · Current Opinion in Urology · doi:10.1097/mou.0000000000000440 · Cited by 16
Male Sexual Dysfunction and Hypogonadism Guidelines for the Aging Male
Ahmed, K., Hatzimouratidis, K., & Muneer, A. (2017) · European Urology Focus · doi:10.1016/j.euf.2017.12.004 · Cited by 15
Testosterone replacement therapy is associated with an increased risk of urolithiasis
McClintock, T. R., Valovska, M.-T. I., Kwon, N. K., Cole, A. P., Jiang, W., Kathrins, M. N., Bhojani, N., Haleblian, G. E., Koehlmoos, T. P., Haider, A. H., et al. (2019) · World Journal of Urology · doi:10.1007/s00345-019-02726-6 · Cited by 18
Self-citationShahine, H., Zanaty, M., Zakaria, A. S., Nguyen, D., Couture, F., Sadri, I., Schwartz, R., Arezki, A., Elterman, D., El‐Hakim, A., et al. (2020) · World Journal of Urology · doi:10.1007/s00345-020-03475-7 · Cited by 15
Testosterone treatment of late-onset hypogonadism – benefits and risks
Snyder, P. J. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09712-1 · Cited by 15
Self-citationChasland, L. C., Knuiman, M. W., Divitini, M., Murray, K., Handelsman, D. J., Flicker, L. A., Hankey, G. J., Almeida, O. P., Golledge, J., Ridgers, N. D., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13905 · Cited by 15
König, C. S., Balabani, S., Hackett, G. I., Strange, R. C., & Ramachandran, S. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2019.01.003 · Cited by 15
Matsumoto, A. M. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.04.004 · Cited by 15
Self-citationThe medicalization of testosterone: reinventing the elixir of life
Gagliano‐Jucá, T., Álvarez, M., & Basaria, S. S. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09751-8 · Cited by 16
Self-citationSymptoms of Late-Onset Hypogonadism in Men
Snyder, P. J. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.04.001 · Cited by 14
Self-citationAndrogens as the “old age stick” in skeletal muscle
Gentile, G., Stefano, F. D., Sorrentino, C., D’Angiolo, R., Lauretta, C., Giovannelli, P., Migliaccio, A., Castoria, G., & Donato, M. D. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02163-6 · Cited by 18
Testicular responses to hCG stimulation at varying doses in men with spinal cord injury
Bauman, W. A., Fountaine, M. F. L., Cirnigliaro, C. M., Kirshblum, S., & Spungen, A. M. (2017) · Spinal Cord · doi:10.1038/sc.2017.8 · Cited by 14
Cardiovascular impact of testosterone therapy for hypogonadism
Rastrelli, G., Dicuio, M., Reismann, Y., Sforza, A., Maggi, M., & Corona, G. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1510314 · Cited by 14
Optimizing Diagnostic Accuracy and Treatment Decisions in Men With Testosterone Deficiency
Bhasin, S., & Ozimek, N. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.08.002 · Cited by 15
Self-citationRole of circulating molecules in age-related cardiovascular and metabolic disorders
Hsiao, Y., Shimizu, I., Yoshida, Y., & Minamino, T. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-021-00187-2 · Cited by 16
Alsuliman, T., Jondreville, L., Baylet, C., Dann, M.-P., Bentzmann, N. D., Fontoura, M., Genty, C., Huynh, A., Ibled, D., Yakoub‐Agha, I., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051196 · Cited by 14
Falqueto, H., dos Santos, M. R., & Manfredi, L. H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.838526 · Cited by 16
Benefits and Risks of Testosterone Treatment of Older Men with Hypogonadism
Galbiati, F., Goldman, A. L., Gattu, A. K., Guzelce, E. C., & Bhasin, S. (2022) · Urologic Clinics of North America · doi:10.1016/j.ucl.2022.07.011 · Cited by 14
Self-citationTestosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality
Pantalone, K. M., George, J., Ji, X., Kattan, M. W., Milinovich, A., Bauman, J. M., Burguera, B. G., Zimmerman, R. S., & Misra‐Hebert, A. D. (2019) · Basic and Clinical Andrology · doi:10.1186/s12610-019-0085-7 · Cited by 14
Peng, R., Dai, W., Li, D., & Li, Y. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.06.026 · Cited by 15
Sood, A., Hosseinpour, A., Sood, A., Avula, S., Durrani, J., Bhatia, V., & Gupta, R. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.09.012 · Cited by 20
Grossmann, M., Robledo, K. P., Daniel, M., Handelsman, D. J., Inder, W. J., Stuckey, B. G. A., Yeap, B. B., Fui, M. N. T., Bracken, K., Allan, C. A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae085 · Cited by 14
Mechanisms of erectile dysfunction induced by aging: A comprehensive review
Zhuang, B., Zhuang, C., Jiang, Y., Zhang, J., Zhang, Y., Zhang, P., Yu, X., & Xu, S. (2024) · Andrology · doi:10.1111/andr.13778 · Cited by 16
Aging and sex hormones in males
Decaroli, M. C., Vincentis, S. D., & Rochira, V. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2020.12.014 · Cited by 14
Taniguchi, H., Shimada, S., & Kinoshita, H. (2021) · Urologia Internationalis · doi:10.1159/000520135 · Cited by 13
Gaps in Patient Knowledge About Risks and Benefits of Testosterone Replacement Therapy
Gilbert, K., Cimmino, C. B., Beebe, L. C., & Mehta, A. (2017) · Urology · doi:10.1016/j.urology.2016.12.066 · Cited by 13
Emotions and Steroid Secretion in Aging Men: A Multi—Study Report
Walther, A., Waldvogel, P., Noser, E., Schoch-Ruppen, J., & Ehlert, U. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.01722 · Cited by 11
Basit, A., Amory, J. K., & Prasad, B. (2018) · Clinical and Translational Science · doi:10.1111/cts.12569 · Cited by 15
Artz, A. S., Stephens‐Shields, A. J., Bhasin, S., Ellenberg, S. S., Cohen, H. J., & Snyder, P. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa521 · Cited by 14
Self-citationDirect-to-Consumer Advertising of Androgen Replacement Therapy
Kravitz, R. L. (2017) · JAMA · doi:10.1001/jama.2017.1364 · Cited by 13
The Illusory Case for Treatment of an Invented Disease
Handelsman, D. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.682620 · Cited by 12
Figueiredo, M. G., Gagliano‐Jucá, T., & Basaria, S. S. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.12.002 · Cited by 12
Self-citationLong Term Cardiovascular Safety of Testosterone Therapy: A Review of the TRAVERSE Study
Hackett, G. I. (2024) · The World Journal of Men s Health · doi:10.5534/wjmh.240081 · Cited by 13
Matsukawa, A., Yanagisawa, T., Rajwa, P., Fazekas, T., Miszczyk, M., Tsuboi, I., Parizi, M. K., Laukhtina, E., Klemm, J., Chiujdea, S., et al. (2024) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2024.102251 · Cited by 12
Depression in Nonclassical Hypogonadism in Young Men
Korenman, S. G., Grotts, J. F., Bell, D. S., & Elashoff, D. A. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00137 · Cited by 12
Testosterone replacement therapy and the heart: friend, foe or bystander?
López, D. S., Canfield, S. E., & Wang, R. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.10.02 · Cited by 12
Pharmacoepidemiology of testosterone: Curbing off‐label prescribing
Handelsman, D. J. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4284 · Cited by 12
Yeap, B. B., Marriott, R. J., Adams, R., Antonio, L., Ballantyne, C. M., Bhasin, S., Cawthon, P. M., Couper, D. J., Dobs, A. S., Flicker, L. A., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034777 · Cited by 12
Self-citationTestosterone deficiency syndrome: Diagnosis and treatment
García-Cruz, E., & Alcaraz, A. (2020) · Actas Urológicas Españolas (English Edition) · doi:10.1016/j.acuroe.2019.10.008 · Cited by 12
Osadchiy, V., Jiang, T., Mills, J. N., & Eleswarapu, S. V. (2020) · Journal of Medical Internet Research · doi:10.2196/21383 · Cited by 12
Morgentaler, A., Abello, A., & Bubley, G. J. (2021) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2021.0001 · Cited by 12
Yan, Z., & Lei, T. (2022) · Brain Sciences · doi:10.3390/brainsci12060796 · Cited by 12
The Role of Hormones in Male Sexual Function
Dick, B. P., Koller, C. R., Herzog, B. J., Greenberg, J. W., & Hellstrom, W. J. G. (2020) · Current Sexual Health Reports · doi:10.1007/s11930-020-00271-7 · Cited by 16
Testosterone and Male Sexual Function
Galansky, L. B., Levy, J. A., & Burnett, A. L. “. (2022) · Urologic Clinics of North America · doi:10.1016/j.ucl.2022.07.006 · Cited by 11
Xu, Z., Chen, X., Zhou, H., Ren, C., Wang, Q., Pan, Y., Liu, L., & Liu, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1335146 · Cited by 11
Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy
Davidiuk, A. J., & Broderick, G. A. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.09.02 · Cited by 13
Handelsman, D. J. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5080 · Cited by 11
Blood donation and testosterone replacement therapy
Chin-Yee, B. H., Lazo‐Langner, A., Butler‐Foster, T., Hsia, C. C., & Chin-Yee, I. H. (2017) · Transfusion · doi:10.1111/trf.13970 · Cited by 10
Effect of androgen supplementation on 24-hour activity-rest patterns of aged male rhesus macaques
Urbanski, H. F. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.02.020 · Cited by 11
Metadata
- Authors
- Snyder, P. J., Bhasin, S., Cunningham, G. R., Matsumoto, A. M., Stephens-Shields, A. J., Cauley, J. A., Gill, T. M., Barrett-Connor, E., Swerdloff, R. S., Wang, C., Ensrud, K. E., Lewis, C. E., Farrar, J. T., Cella, D., Rosen, R. C., Pahor, M., Crandall, J. P., Molitch, M. E., Cifelli, D., Dougar, D., Fluharty, L., Resnick, S. M., Storer, T. W., Anton, S., Basaria, S., Diem, S. J., Hou, X., Mohler, E. R., Parsons, J. K., Wenger, N. K., Zeldow, B., Landis, J. R., & Ellenberg, S. S.
- Affiliations
- University of Pennsylvania (US)
- Brigham and Women's Hospital (US)
- Baylor College of Medicine (US)
- University of Washington (US)
- From the Division of Endocrinology, Diabetes, and Metabolism (P.J.S.), the Department of Biostatistics and Epidemiology (A.J.S.-S., J.T.F., X.H., B.Z., J.R.L., S.S.E.), the Center for Clinical Epidemiology and Biostatistics (D. Cifelli, D.D., L.F.), and the Division of Cardiovascular Disease, Section of Vascular Medicine, Department of Medicine (E.R.M.), Perelman School of Medicine, University of Pennsylvania, Philadelphia; Research Program in Men’s Health: Aging and Metabolism, Brigham and Women’s...
- University of Pittsburgh (US)
- Yale University (US)
- University of California San Diego (US)
- The Lundquist Institute (US)
- University of Minnesota (US)
- Northwestern University (US)
- New England Research Institutes (US)
- University of Florida (US)
- Albert Einstein College of Medicine (US)
- National Institutes of Health (US)
- Emory University (US)
- ORCID
- Snyder, Peter J.
- Bhasin, Shalender
- Cunningham, Glenn R.
- Matsumoto, Alvin M.
- Cauley, Jane A.
- Gill, Thomas M.
- Barrett-Connor, Elizabeth
- Swerdloff, Ronald S.
- Wang, Christina
- Ensrud, Kristine E.
- Lewis, Cora E.
- Farrar, John T.
- Cella, David
- Crandall, Jill P.
- Molitch, Mark E.
- Resnick, Susan M.
- Storer, Thomas W.
- Anton, Stephen
- Basaria, Shehzad
- Diem, Susan J.
- Hou, Xiaoling
- Parsons, J. Kellogg
- Wenger, Nanette K.
- Zeldow, Bret
- Landis, J. Richard
- Ellenberg, Susan S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-02-18
- Volume
- 374
- Issue
- 7
- Pages
- 611-624
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC5209754
- OpenAlex
- W2324158400
- Cited by
- 890
- References
- 40
- Citations by year
- 2026: 49 · 2025: 73 · 2024: 73 · 2023: 97 · 2022: 79 · 2021: 65 · 2020: 81 · 2019: 76 · 2018: 103 · 2017: 106 · 2016: 86
- FWCI
- 124.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5p60dk079626-05, UL1TR000142)
- National Institute on Aging (U01AG030644, P30-AG013679, R01AG037679, K24AG021507, K07AG043587, R01 AG37679, P30AG024827, P30AG028740, P30AG021342)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK079626, P60-DK-079626, P30DK079626)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Keywords
- testosterone replacement therapy, older men, hypogonadism, testosterone gel, sexual function, erectile function, sexual desire, physical function, walking distance, vitality, depressive symptoms, mood, adverse events
- MeSH terms
- Aged, Depression, Double-Blind Method, Fatigue, Humans, Libido, Male, Reference Values, Sexual Behavior, Testosterone, Walking, Prostate-Specific Antigen, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
